MEDIFAST (MED)
(Real Time Quote from BATS)
$26.68 USD
-0.85 (-3.09%)
Updated May 1, 2024 09:43 AM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MED 26.68 -0.85(-3.09%)
Will MED be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for MED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MED
Medifast (MED) Q1 Earnings Miss Estimates, Revenues Fall Y/Y
Medifast's (MED) Transformation on Track Amid Macro Headwinds
MED: What are Zacks experts saying now?
Zacks Private Portfolio Services
MEDIFAST (MED) Down 11.5% Since Last Earnings Report: Can It Rebound?
Medifast (MED) Soars 5.9%: Is Further Upside Left in the Stock?
Innovations Aid Medifast (MED), Lower Customer Attraction Ails
Other News for MED
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Nasdaq Dips Over 100 Points; Coca-Cola Earnings Top Views
Medifast falls -22.8%
MULN and NCI among Consumer Discretionary movers
Dow Tumbles 200 Points; McDonald's Posts Downbeat Earnings